Public Company News

Hyundai Mobis Makes its Debut at NAIAS 2022 to Showcase Future Mobility Technologies for EV and AV

* Hyundai Mobis will exhibit more than 30 next-generation technologies, including its EV platform, lighting grille, integrated cockpit and AR HUD. * Orders from NA automakers totaled $1.7B during 1H '22; Mobis expects further demand for its high-value products. * Hyundai Mobis, the world's s...

2022-09-06 20:00 3416

LAIX Inc. Sets Record Date for Dissemination of Transaction Statement and Plan of Merger for "Going Private" Transaction

SHANGHAI, Sept. 6, 2022 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (OTC:LAIXY), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it has setSeptember 6, 2022 as the record date for the dis...

2022-09-06 20:00 4468

Cloopen Announces the Substantial Completion of the Independent Internal Investigation

BEIJING, Sept. 6, 2022 /PRNewswire/ -- Cloopen Group Holding Limited (NYSE: RAAS) ("Cloopen" or the "Company") today announced that the independent special committee of the Company's Board of Directors (the "Special Committee") has substantially completed its independent internal investigation (t...

2022-09-06 20:00 4246

iQIYI Further Upgrades Online Film Distribution Model to Increase Revenue for Film Producers, Driving Industry Growth

BEIJING, Sept. 6, 2022 /PRNewswire/ -- iQIYI, an innovative market-leading online entertainment service inChina, announced recently that it has further upgraded the revenue sharing system of its Cloud Cinema Premiere model where producers now share most of the revenues earned. The company also di...

2022-09-06 18:13 3371

LightInTheBox Reports Second Quarter 2022 Financial Results

SHANGHAI, Sept. 6, 2022 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a cross-border e-commerce platform that delivers products directly to consumers around the world, today announced its unaudited financial results for the second quarter ended J...

2022-09-06 18:12 4070

Qudian Inc. Reports Second Quarter 2022 Unaudited Financial Results

XIAMEN, China, Sept. 6, 2022 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company inChina, today announced its unaudited financial results for the quarter endedJune 30, 2022.  Second Quarter 2022 Operational Highlights: * Number of...

2022-09-06 18:00 4180

Trip.com Group Limited to Report Second Quarter and First Half of 2022 Financial Results on September 21, 2022 U.S. Time

SHANGHAI, Sept. 6, 2022 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its financial results for the three months an...

2022-09-06 18:00 3330

TAL Education Group to Hold Annual General Meeting on September 16, 2022

BEIJING, Sept. 6, 2022 /PRNewswire/ -- TAL Education Group (NYSE: TAL) ("TAL" or the "Company"), a smart learning solutions provider inChina, today announced that it will hold its annual general meeting of shareholders at 4/F Heying Center,Xiaoying West Street, Haidian District, Beijing, China, o...

2022-09-06 17:30 3667

Amcor reveals Lift-Off seed capital winners with investments that seek to "drive the revolution in packaging"

Global packaging leader to provide US $250,000 to two start-ups with cutting edge innovations for a more sustainable future for packaging ZURICH, Sept. 6, 2022 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, has announced...

2022-09-06 16:10 3949

Jacobio Receives CDE Approval for KRAS G12C Inhibitor JAB-218822's Phase II Pivotal Study in China

BEIJING, SHANGHAI and BOSTON, Sept. 6, 2022 /PRNewswire/ -- Jacobio Pharma (1167.HK) has received Phase II pivotal study approval of KRAS G12C inhibitor JAB-21822 from the Center for Drug Evaluation (CDE) ofChina in September 5, 2022 . This study aims to treat advanced or metastatic non-small cell...

2022-09-06 15:20 2500

SK hynix to Build M15X Fab in Cheongju

* Company to break ground in October, complete construction in early 2025 with plan to invest15 trillion won over 5 years * M15X to be first new fab since company commemorated 10th anniversary this year * Investment during economic downturn to lay foundation for future growth SEOUL, South K...

2022-09-06 14:15 2775

MingZhu Logistics Updates Instructions to Participate in 2022 Annual Meeting via Video Conferencing

SHENZHEN, China, Sept. 5, 2022 /PRNewswire/ -- MingZhu Logistics Holdings Ltd. (NASDAQ: YGMZ) (the "MingZhu" or "Company"), a trucking service provider, today announced updated instructions to participate in the Company's 2022 Annual Meeting via video conferencing to accommodate ongoing COVID con...

2022-09-06 07:45 2456

Dizal Announces Sunvozertinib Meets Primary Endpoint in its First Pivotal Study in Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations at 2022 ESMO

* The confirmed objective response (cORR), as assessed by blinded independent central review (BICR), was 59.8% in advanced NSCLC with EGFR exon20ins mutations after at least one line of platinum-based chemotherapies * The response rate for patients with baseline brain metastasis was 48.4% * ...

2022-09-05 22:49 3501

Dizal Announces Positive Phase I Clinical Trial Results for DZD1516 in Treating HER2 Breast Cancer at 2022 ESMO

PARIS, Sept. 5, 2022 /PRNewswire/ -- Dizal reported the promising safety and pharmacokinetic data from the global Phase I study ofDZD1516 in patients with HER2 positive metastatic breast cancer (HER2+ MBC) who relapsed from multiple prior treatments at the 2022 European Society for Medical Oncolo...

2022-09-05 22:39 3274

GONEO launches the new silent series portable power stations

The series provides users with a comfortable noise-free experience when using electricity outdoors NINGBO, China, Sept. 5, 2022 /PRNewswire/ -- GONEO , an international brand owned by Gongniu Group, a Chinese manufacturer of consumer-demand oriented electrical products, h...

2022-09-05 21:15 5687

Recruitment opens for Phase II trial in prostate cancer with Cu-64 SAR-Bombesin in the US

SYDNEY, Sept. 5, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that the US-based diagn...

2022-09-05 21:09 3429

Lunit to Showcase 5 Abstracts at ESMO 2022

* Lunit to present five posters at ESMO 2022 featuring the company's AI-biomarker platform * Studies corroborate the capability of Lunit SCOPE suite to address an expanding set of clinical and research questions based on world-leading digital pathology AI SEOUL, South Korea, Sept. 5, 2022 /PR...

2022-09-05 21:00 3437

Boqii Announces Senior Management Change

SHANGHAI, Sept. 5, 2022 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE: BQ), a leading pet-focused platform inChina, today announced that Mr.Kai Fang has resigned from his position as the Company's Chief Strategy Officer and all his roles as a director or an officer of the...

2022-09-05 20:00 3631

JDDJ at CIFTIS: On-demand retail in action to assist real economy and boost consumption

BEIJING, Sept. 5, 2022 /PRNewswire/ -- As the only on-demand retail industry representative at the New Digital Consumption Forum of the China International Fair for Trade in Services (CIFTIS) inBeijing this year, General Manager of JDDJ Mr.Changming Li gave a speech to discuss how JDDJ supports r...

2022-09-05 19:50 3856

Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. announce a research collaboration in the field of anti-infectives

CHENGDU, China, Sept. 5, 2022 /PRNewswire/ -- Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. ("Unison") are pleased to announce a research collaboration on an undisclosed bacterial target. Under the terms of the agreement, Vernalis will use it...

2022-09-05 16:00 3517
1 ... 593594595596597598599 ... 749